In HepG2.117 cells, ALG-001075 achieved HBV DNA EC50 0.64 nM, outperforming canocapavir (5.8 nM) and neracorvir (24 nM) with ...
Researchers evaluated an allogeneic umbilical cord cell therapy in T1DM. A single dose provided durable insulin preservation, ...
Increased integration of artificial intelligence–based tools across the discovery and engineering of tumor-targeting engagers and multi-domain proteins to accelerate development while reducing ...
Cory Ellspermann noted the net loss increased to $45.9 million from $42.1 million, reflecting sustained high operating losses ...
GT Biopharma Inc. (NASDAQ:GTBP) on Monday said its recently implemented artificial intelligence-based technologies are ...
Collaboration Combines Best-in-Class Biology with Agile AI and Chemistry Automation for Rapid Discovery of Better Molecules for Highly Valuable G Protein-Coupled Receptor (GPCR) Targets MENLO PARK, ...
Targeted extended circulation LNP incorporating DARPins achieved complete B cell depletion in nonhuman primates through highly specific in vivo CD8+ T cell engineeringRobust study quantifies ...
Opus Genetics Virtual R&D Science Forum Scheduled for Tuesday, June 16, 2026, at 10:00 am ETUpcoming Data Readout for Cohort 1 of OPGx-BEST1 ...
At AACR 2026, industry leaders discussed how oncology R&D is moving beyond isolated technological advances towards integrated ...
Xencor (NASDAQ:XNCR) used a webcast during Digestive Disease Week 2026 to highlight Phase I results for its TL1A-targeting monoclonal antibody XmAb942 and to outline preclinical data supporting ...
On track for August 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for ...
A team of chemists in Tokyo has built synthetic compounds derived from vitamin K that coax brain stem cells into becoming new ...